LEMAITRE (LMAT) President David B. Roberts Receives Stock Awards

What Happened
David B. Roberts, President and a director of Lemaître Vascular, acquired a total of 24.907 derivative shares (dividend-equivalent rights) on September 3, 2026. These were recorded as awards/grants (transaction code A) at $0.00 per share—i.e., they represent accrued dividend equivalents tied to previously granted restricted stock units (RSUs) and performance share units (PSUs), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-03; Form 4 filed: 2026-09-08 (five days later). This exceeds the typical 2-business-day Form 4 filing window.
• Items acquired: nine separate dividend-equivalent awards totaling 24.907 shares (individual amounts: 2.126, 2.126, 3.632, 4.352, 3.157, 3.576, 0.306, 0.345, 5.287). Price per share reported: $0.00; cash value: $0.
• Shares owned after the transaction: not disclosed in the provided filing.
• Footnotes: each item is a dividend-equivalent right that accrued on RSU or PSU awards granted on various prior dates (12/12/2022; 12/8/2023; 12/6/2024; 2/18/2025; 12/10/2025). Each dividend equivalent is the economic equivalent of one share and vests proportionately with the underlying award.
• Transaction type: derivative award (A). No tax withholding, sale, or exercise was reported in this filing.

Context
These entries are dividend-equivalent accruals tied to earlier equity awards—routine compensation mechanics that increase an executive's effective share holdings without cash changing hands. Such derivative awards differ from open-market purchases (which may signal bullishness) or sales (which may signal liquidity needs); they reflect vested compensation adjustments rather than a trading decision.